News

Regulatory affairsRegulatory Round-up - April 2026
Filter:AllPress ReleaseCell TherapiesGene TherapiesDigital and AutomationSpin-outs, Start-ups, Sector investmentManufacturingRegulatory affairsSkills and Training
Year:All2026202520242023 →
CGT Catapult leads industry consortium developing universal test to increase the safety and efficiency of stem cell therapiesCGT Catapult leads industry consortium developing universal test to increase the safety and efficiency of stem cell therapiesCGT Catapult to take part in consortium aiming to improve the sustainability of CAR-T manufacturingCGT Catapult to take part in consortium aiming to improve the sustainability of CAR-T manufacturingRegulatory Round-up - November 2025Regulatory Round-up - November 2025CGT Catapult annual review highlights the role of advanced therapies in supporting Government ambitions for public health and economic growthCGT Catapult annual review highlights the role of advanced therapies in supporting Government ambitions for public health and economic growthRegulatory Round-up - October 2025Regulatory Round-up - October 2025CGT Catapult awarded two Princess Royal Training Awards for its skills and training programmesCGT Catapult awarded two Princess Royal Training Awards for its skills and training programmesNew evaluation model finds widespread adoption of cell and gene therapies may unlock billions for the UK economyNew evaluation model finds widespread adoption of cell and gene therapies may unlock billions for the UK economyUnderstanding life with Beta ThalassemiaUnderstanding life with Beta ThalassemiaCGT Catapult and Autolomous showcase benefits of digital technologies in advanced therapy manufacturingCGT Catapult and Autolomous showcase benefits of digital technologies in advanced therapy manufacturingRegulatory Round-up - September 2025Regulatory Round-up - September 2025CGT Catapult supporting VascVersa to develop pre-treatment test to ensure efficacy of cell therapy that regenerates blood vesselsCGT Catapult supporting VascVersa to develop pre-treatment test to ensure efficacy of cell therapy that regenerates blood vesselsThe case for collaboration: Why going it alone is no longer an option in advanced therapy developmentThe case for collaboration: Why going it alone is no longer an option in advanced therapy development